Phase 2 study of rituximab in the treatment of cladribine-failed patients with hairy cell leukemia.

Nieva J, Bethel K, Saven A

Hairy cell leukemia: an update.

Goodman GR, Bethel KJ, Saven A

Cladribine in the treatment of hairy-cell leukaemia.

Goodman GR, Beutler E, Saven A

Extended follow-up of patients with hairy cell leukemia after treatment with cladribine.

Goodman GR, Burian C, Koziol JA, Saven A

Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study.

Sawyers CL, Hochhaus A, Feldman E, Goldman JM, Miller CB, Ottmann OG, Schiffer CA, Talpaz M, Guilhot F, Deininger MW, Fischer T, O'Brien SG, Stone RM, Gambacorti-Passerini CB, Russell NH, Reiffers JJ, Shea TC, Chapuis B, Coutre S, Tura S, Morra E, Larson RA, Saven A, Peschel C, Gratwohl A, Mandelli F, Ben-Am M, Gathmann I, Capdeville R, Paquette RL, Druker BJ